Go
Print

Chapter 69.41 RCW

LEGEND DRUGS—PRESCRIPTION DRUGS

Sections

HTMLPDF 69.41.010Definitions.
HTMLPDF 69.41.020Prohibited acts—Information not privileged communication.
HTMLPDF 69.41.030Sale, delivery, possession, or use of legend drug without prescription or order prohibited—Exceptions—Penalty—Referral to assessment and services.
HTMLPDF 69.41.032Prescription of legend drugs and dialysate by dialysis programs.
HTMLPDF 69.41.040Prescription requirements—Penalty.
HTMLPDF 69.41.041Long-term care facilities and hospice programs—Legend drug prescriptions and chart orders.
HTMLPDF 69.41.042Record requirements.
HTMLPDF 69.41.044Confidentiality.
HTMLPDF 69.41.050Labeling requirements—Penalty.
HTMLPDF 69.41.055Electronic communication of prescription information—Commission may adopt rules—Long-term care facilities and hospice programs.
HTMLPDF 69.41.060Search and seizure.
HTMLPDF 69.41.062Search and seizure at rental premises—Notification of landlord.
HTMLPDF 69.41.065Violations—Juvenile driving privileges.
HTMLPDF 69.41.072Violations of chapter 69.50 RCW not to be charged under chapter 69.41 RCW—Exception.
HTMLPDF 69.41.075Rules—Availability of lists of drugs.
HTMLPDF 69.41.080Animal control—Rules for possession and use of legend drugs.
HTMLPDF 69.41.085Medication assistance—Community-based care setting.
HTMLPDF 69.41.095Opioid overdose reversal medication—Standing order permitted.
SUBSTITUTION OF PRESCRIPTION DRUGS
HTMLPDF 69.41.100Legislative recognition and declaration.
HTMLPDF 69.41.110Definitions.
HTMLPDF 69.41.120Prescriptions to contain instruction as to whether or not a therapeutically equivalent generic drug or interchangeable biological product may be substituted—Out-of-state prescriptions—Form—Contents—Procedure.
HTMLPDF 69.41.125Interchangeable biological product may be substituted for biological product—Exception—Wholesale price less.
HTMLPDF 69.41.130Savings in price to be passed on to purchaser.
HTMLPDF 69.41.140Minimum manufacturing standards and practices.
HTMLPDF 69.41.150Liability of practitioner, pharmacist.
HTMLPDF 69.41.160Pharmacy signs as to substitution for prescribed drugs.
HTMLPDF 69.41.170Coercion of pharmacist prohibited—Penalty.
HTMLPDF 69.41.180Rules.
HTMLPDF 69.41.190Preferred drug substitution—Exceptions—Notice—Limited restrictions.
HTMLPDF 69.41.193Dispensing of biological product—Entry of product into electronic records system—Communication—Exceptions.
HTMLPDF 69.41.196List of interchangeable biological products—Pharmacy quality assurance commission to maintain link on website.
IDENTIFICATION OF LEGEND DRUGS—MARKING
HTMLPDF 69.41.200Requirements for identification of legend drugs—Marking.
HTMLPDF 69.41.210Definitions.
HTMLPDF 69.41.220Published lists of drug imprints—Requirements for.
HTMLPDF 69.41.230Drugs in violation are contraband.
HTMLPDF 69.41.240Rules—Labeling and marking.
HTMLPDF 69.41.250Exemptions.
HTMLPDF 69.41.260Manufacture or distribution for resale—Requirements.
HTMLPDF 69.41.280Confidentiality.
USE OF STEROIDS
HTMLPDF 69.41.300Definitions.
HTMLPDF 69.41.310Rules.
HTMLPDF 69.41.320Practitioners—Restricted use—Medical records.
HTMLPDF 69.41.330Public warnings—School districts.
HTMLPDF 69.41.340Student athletes—Violations—Penalty.
HTMLPDF 69.41.350Penalties.

NOTES:

Drug nuisances—Injunctions: Chapter 7.43 RCW.
Site Contents
Selected content listed in alphabetical order under each group



Translate